{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Predictive Oncology Inc."},"Symbol":{"label":"Symbol","value":"POAI"},"Address":{"label":"Address","value":"2915 COMMERS DRIVE,SUITE 900, EAGAN, Minnesota, 55121, United States"},"Phone":{"label":"Phone","value":"+1 651 389-4800"},"Industry":{"label":"Industry","value":"Industrial Specialties"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response."},"CompanyUrl":{"label":"Company Url","value":"https://www.predictive-oncology.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Lawrence J. DeLucas","title":"Vice President-Operations"},{"name":"Raymond F. Vennare","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}